WATCH: Trump unveils deal with Regeneron to lower its drug prices for Medicaid
Summary
President Donald Trump announced a deal with the drug company Regeneron to lower prices for its medicines on Medicaid, the government program for low-income people. The deal includes selling a cholesterol drug called Praluent for $225 on the White House's discounted drug website, TrumpRx.Key Facts
- President Trump revealed the deal on a Thursday announcement.
- Regeneron agreed to lower prices on all current and future drugs sold through Medicaid.
- The cholesterol drug Praluent will be sold for $225 on the TrumpRx website.
- TrumpRx is a White House website offering discounted drug prices.
- The deal is part of the Trump administration's effort to reduce drug costs.
- These efforts come ahead of the November midterm elections.
- Many Americans are concerned about high costs for health care and other basic needs.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.